Absci

​

Absci is unlocking the potential of next-generation biologics by harnessing deep learning AI and synthetic biology to explore a vast therapeutic sequence space inaccessible to conventional discovery methods.

Landos Biopharma

​

Landos Biopharma Inc is a clinical-stage company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases.

Pipeline Therapeutics

​

Pipeline Therapeutics is focused on  developing first-in-class molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair.

Ribbon Biolabs

​

Ribbon Biolabs is a synthetic biology company advancing a new technology for the automated synthesis of long DNA molecules to enable innovation in the life sciences.

Crown Bioscience

​

CrownBio is helping provide clarity of action in the fight against cancer and diabetes. Acquired by JSR Life Sciences

Tangible Science

​

Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases. Tangible's technology has the potential to be used from consumer contact lens to smart contact lens.

X-Vax

​

X-VAX is on a quest to defeat herpes by harnessing the power of antibodies that mediate the killing of infected cells.

Medeon

​

Medeon designs, develops, and manufactures high-value, high-impact medical device solutions that will transform healthcare.

Totient Bio

​

Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. Acquired by Absci

Ausnutria

​

Ausnutria is a global dutch company specializing in infant care products from new infant formulas and probiotics. Acquired by Yili

Lumosa Therapeutics

​

Lumosa Therapeutics is a clinical-stage pharmaceutical company developing novel therapies and solutions for neurological and oncological diseases

TOT Biopharm

​

TOT Biopharm is dedicated to developing innovative oncology drugs.